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James E Bennett*, Guangquan Li*, Kyle Foreman, Nicky Best, Vasilis Kontis, Clare Pearson, Peter Hambly, Majid Ezzati
Summary
Background To plan for pensions and health and social services, future mortality and life expectancy need to be 
forecast. Consistent forecasts for all subnational units within a country are very rare. Our aim was to forecast mortality 
and life expectancy for England and Wales’ districts.
Methods We developed Bayesian spatiotemporal models for forecasting of age-speciﬁ c mortality and life expectancy at 
a local, small-area level. The models included components that accounted for mortality in relation to age, birth cohort, 
time, and space. We used geocoded mortality and population data between 1981 and 2012 from the Oﬃ  ce for National 
Statistics together with the model with the smallest error to forecast age-speciﬁ c death rates and life expectancy to 
2030 for 375 of England and Wales’ 376 districts. We measured model performance by withholding recent data and 
comparing forecasts with this withheld data.
Findings Life expectancy at birth in England and Wales was 79·5 years (95% credible interval 79·5–79·6) for men and 
83·3 years (83·3–83·4) for women in 2012. District life expectancies ranged between 75·2 years (74·9–75·6) and 
83·4 years (82·1–84·8) for men and between 80·2 years (79·8–80·5) and 87·3 years (86·0–88·8) for women. Between 
1981 and 2012, life expectancy increased by 8·2 years for men and 6·0 years for women, closing the female–male gap 
from 6·0 to 3·8 years. National life expectancy in 2030 is expected to reach 85·7 (84·2–87·4) years for men and 
87·6 (86·7–88·9) years for women, further reducing the female advantage to 1·9 years. Life expectancy will reach or 
surpass 81·4 years for men and reach or surpass 84·5 years for women in every district by 2030. Longevity inequality 
across districts, measured as the diﬀ erence between the 1st and 99th percentiles of district life expectancies, has risen 
since 1981, and is forecast to rise steadily to 8·3 years (6·8–9·7) for men and 8·3 years (7·1–9·4) for women by 2030.
Interpretation Present forecasts underestimate the expected rise in life expectancy, especially for men, and hence the 
need to provide improved health and social services and pensions for elderly people in England and Wales. Health 
and social policies are needed to curb widening life expectancy inequalities, help deprived districts catch up in 
longevity gains, and avoid a so-called grand divergence in health and longevity.
Funding UK Medical Research Council and Public Health England.
Copyright © Bennett et al. Open Access article distributed under the terms of CC BY.
Introduction
To plan for health and social services and pensions, 
forecasts of future mortality and life expectancy are 
needed.1,2 These forecasts have been done for one or 
more countries.3–11 Consistent forecasts for all subnational 
units within a country are very rare,12 even though 
mortality and life expectancy vary substantially within 
countries, both geographically and in relation to social 
class. Planning and priority setting at the subnational 
level need local mortality forecasts. Local information is 
especially important in countries like the UK that are 
devolving health and social care responsibilities to local 
governments to ensure that such decentralisation, which 
might particularly reduce services in deprived areas, does 
not worsen health inequalities.
In this study, we used the methods of Bayesian 
(spatiotemporal) statistics to develop new approaches to 
forecasting of future mortality and life expectancy at a 
local, small-area level. We applied these methods to more 
than three decades of geocoded data from England and 
Wales’ districts to estimate past trends and forecast 
future mortality and life expectancy by district.
Methods
Study design
We analysed trends from 1981 to 2012 and forecast 
age-speciﬁ c death rates to 2030. The age groups in our 
analysis were 0 years, 1–4 years, 5 year age groups up to 
84 years, and 85 years and older. We did not further 
divide the last age group because district population 
data were not further divided into age groups older than 
age 85 years before 1991. We used age-speciﬁ c death 
rates to calculate life expectancy. Our analysis units 
were 375 of the 376 districts in England and Wales. We 
do not present estimates for the Isles of Scilly to comply 
with the Oﬃ  ce for National Statistics (ONS) data 
disclosure policies for units with populations of less 
than 5000.
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Data
We used data for deaths in England and Wales between 
1981 and 2012 (nearly 17 250 000 death records) held by 
the UK Small Area Health Statistics Unit and supplied 
by ONS. Data use was approved by the National 
Research Ethics Service (reference 12/LO/0566 and 
12/LO/0567) and the National Information Governance 
Board and Ethics and Conﬁ dentiality Committee 
(approval for section 251 support [HRA—14/CAG/1039]). 
Age, sex, date of death, and postcode of residence were 
available for each record; we used postcodes to assign 
deaths to districts. Population data by age and sex for 
each district for 1981–2012 were from ONS. We also 
used ONS’ district population projections with methods 
described elsewhere.13 Brieﬂ y, the present cohorts in 
each district are brought forward in time in 1 year 
increments and adjusted by district-level fertility, 
mortality, and migration; these demographic factors are 
themselves projected on the basis of recent trends.
Statistical analysis
We used ﬁ ve forecasting models that were formulated 
to incorporate features of death rates in relation to age 
and birth cohort, and over time and space. Model speciﬁ -
cations are provided in the appendix. We selected the 
model that had the smallest forecast error for reporting 
of results.
Death rates vary with age, and their age association 
tends to have a smooth pattern. Therefore, in models 
1–4, we allowed each age group to have a diﬀ erent 
mortality level and trend, but modelled age group 
intercepts and slopes using a random walk structure 
that is widely used to characterise smoothly varying 
associations (appendix).14 This approach improves 
stability of death rates in each age group and avoids 
implausible age patterns of mortality that could occur if 
each age group is analysed separately.7,15
Because time trends in death rates can be non-linear, 
we modelled time trends (of log-transformed death 
rates) using a linear term plus a smoothly varying 
non-linear term, speciﬁ ed with a random walk 
(model 1).14 Additionally, we formulated one of the 
models to have time trends that are faster or slower than 
linear through inclusion of an exponent on the trend 
term (model 2).
Diﬀ erent birth cohorts can have diﬀ erent mortality 
experiences—eg, risk factors like smoking or fetal or 
early-life determinants of health having cohort patterns. 
To take account of this characteristic, we formulated 
two of the models with a cohort component in trends, 
allowing trends to be more similar in adjacent birth 
cohorts than in those born in diﬀ erent eras using a 
random walk structure (models 3 and 4). One of these 
models (model 4) allowed the role of birth cohort to be 
more important in speciﬁ c ages—eg, in older ages if 
mortality is aﬀ ected by cumulative life-course risks, with 
use of an age-speciﬁ c weight on the cohort term.
Finally, death rates, and change in death rates, might 
be more similar in neighbouring districts than in those 
farther away. We used the Besag, York, and Mollie spatial 
model, described in the appendix and elsewhere,16 which 
allows death rates and their trends in each district to be 
estimated on the basis of their own data and those of its 
neighbours. The extent to which neighbours share 
information depends on how uncertain death rates in 
each district are, and on the empirical similarity of 
neighbouring districts.
In addition to these four models, we implemented a 
model premised on the widely used Lee–Carter method, 
with the addition of a spatial component for district-level 
forecasting (model 5).5 We ﬁ tted models 1 and 3–5 with 
the Markov chain Monte Carlo algorithm in WinBUGS 
1.4.3 and, to improve mixing, ﬁ tted model 2 in Stan 2.2.0, 
which uses an implementation of Hamiltonian Monte 
Carlo. We monitored convergence using trace plots 
and Brooks–Gelman–Rubin diagnostics,17 and collected 
8000 postburn-in samples for inference and forecast. The 
reported 95% credible intervals represent the 2·5th to 
97·5th percentiles of the posterior distribution of 
estimated death rates and life expectancies.
All analyses were sex-speciﬁ c because mortality levels 
and trends diﬀ er by sex. We calculated national death 
rates for each age group as the population-weighted 
average of district death rates. We calculated life 
expectancies using life table methods.18 We used the 
Kannisto-Thatcher method to expand the terminal 
(85 years and older) age group of the life table.19 This 
method is designed for use in low-mortality populations 
and is used by the UN Population Division, WHO,20 the 
Human Mortality Database,21 and The Lancet Series on 
ageing.22 We calculated the contribution of speciﬁ c age 
groups to life expectancy change using the so-called 
discrete method, as described elsewhere.18 
Model performance
To assess performance of the forecasting models, we used 
the ﬁ rst 21 years of data (1981–2001) to estimate model 
parameters, which we then used to forecast for 2002–12, 
for which data were available but withheld. We compared 
forecasts from each model with the withheld data, and 
report forecast error (which measures systematic bias) 
and absolute forecast error (which measures any deviation 
from the data) for both life expectancy and age-speciﬁ c 
death rates. Additionally, we report coverage of forecast 
uncertainty; if forecast death rates and their uncertainties 
are well estimated, estimated 90% credible intervals 
should cover 90% of the withheld data.
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. JEB, GL, VK, and PH had full access to all the 
data in the study and the corresponding author had ﬁ nal 
responsibility for the decision to submit for publication.
See Online for appendix
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Results
Detailed results on model performance are provided in the 
appendix. All ﬁ ve forecasting models had small in-sample 
errors—ie, their estimates were consistent with the 
observed data in years for which data were available and 
used in the model. However, forecast (out-of-sample) errors 
of the models diﬀ ered, with the model that had a cohort 
component (model 3) having the smallest error. Forecasts 
from this model were almost unbiased (mean forecast 
error 0·01 years for both men and women). Their median 
absolute error was only 0·559 years (IQR 0·265–0·959) for 
men and 0·580 years (0·275–1·025) for women, better than 
that of the other four models. All other models 
underestimated future life expectancy, with mean forecast 
errors (ie, bias) ranging from 0·121 years for women in 
model 4 to 0·827 years for men in model 5 (appendix). We 
noted no systematic time trend to errors in model 3, 
whereas the bias and error in other models increased with 
increasing forecast period. Model 3 had the lowest mean 
forecast error in 12 (32%) of 38 age-sex groups and the 
lowest mean absolute forecast error in 16 (42%) of 
38 age-sex groups, better than that of all other models. 
Results are therefore shown for model 3 hereafter. With 
very few exceptions, 90% coverage for all models and age 
groups ranged between 85% and 98%, with averages of 
between 92% and 94% for diﬀ erent models. Forecasts with 
coverages of greater than 90% might be viewed as slightly 
overcautious, allowing some more extreme outcomes to be 
considered than those that might actually occur.
Parameters for model 3, shown in the appendix, show 
that death rates in England and Wales had the well-known 
J-shaped age association, being high in the ﬁ rst year of life 
before falling rapidly and then rising gradually to old ages. 
For women, the rise in death rates was smooth throughout 
the whole age range; for men, a sharp increase occurred 
between 10–14 years and 15–19 years. This sex diﬀ erence 
shows excess mortality in young men compared with 
women, which continues through middle ages.
Life expectancy at birth in England and Wales was 
79·5 years (95% credible interval 79·5–79·6) for men 
and 83·3 years (83·3–83·4) for women in 2012 (ﬁ gure 1). 
Between 1981 and 2012, life expectancy increased by 
8·2 years for men and 6·0 years for women, closing the 
female–male gap from 6·0 years in 1981 to 3·8 years 
in 2012. The mortality reductions that led to this 
improvement were uneven across ages, with average 
reductions of 40% or more in middle and old ages, and 
even larger reductions in children and adolescents, but 
smaller reductions in young adults, especially in men 
(ﬁ gure 2).
District life expectancy in 2012 ranged from 75·2 years 
(95% credible interval 74·9–75·6) to 83·4 years (82·1–84·8) 
for men, and from 80·2 years (79·8–80·5) to 87·3 years 
(86·0–88·8) for women (ﬁ gure 3). The 8 year range for 
men is about the same as the diﬀ erence between the UK 
and Sri Lanka or Vietnam in 2012; for women, the 7 year 
range is the same as the diﬀ erence between the UK and 
Malaysia or Nicaragua.23 Life expectancy was lowest in 
urban northern England (including Blackpool, Liverpool, 
and Manchester) and southern Wales, and highest in 
southern England and some of London’s more aﬄ  uent 
districts. Within London, male and female life expectancies 
varied by 5–6 years between working-class Barking and 
Dagenham or Tower Hamlets (lowest) and the small 
district of City of London and wealthy Kensington and 
Chelsea (highest).
Figure 1: Trends and forecasts of (A) district and (B) national life expectancies
The solid line in A shows national life expectancy and each point shows life expectancy for one district. In B, 
national life expectancy is shown with its 95% credible interval, together with life expectancy estimates and 
forecasts (principal variant) for England and Wales from ONS.25 The vertical dashed line shows when forecasts 
begin. The outlier district with high life expectancy is the City of London. The district of the City of London is 
geographically small and largely made up of oﬃ  ces for ﬁ nancial services companies. Its population was about 
7500 in 2012 (compared with an average of around 149 000 in other districts), with very few residents being 
older than 65 years of age. Although the death rates are lower in the City of London than in other districts, its 
estimated death rates and life expectancy have much greater uncertainty than do those of other districts. 
ONS=Oﬃ  ce for National Statistics.
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Figure 2: Decrease in death rates between 1981 and 2012 by age group in England and Wales’ districts
The solid line shows national decrease and each point shows change in one district. The dashed line represents no 
change in death rate.
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Between 1981 and 2012, district life expectancies 
increased by between 5·9 years and 11·3 years for men 
and between 4·0 years and 9·5 years for women. Life 
expectancy gains varied substantially across districts 
because large cross-district variations exist in how much 
age-speciﬁ c death rates declined (ﬁ gure 2). We noted no 
Figure 3: Life expectancy in England and Wales’ districts in (A) 2012 and (B) 2030
The insets are enlarged views of London.
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clear geographical pattern in life expectancy gain, with 
large and small gains seen in both the north and south of 
England and Wales (results not shown). Within London, 
male life expectancies in Kensington and Chelsea 
increased by 3·4 years (95% CI 2·7–4·1) more than in the 
deprived Lewisham, with female life expectancies 
increasing by 2·6 years (1·7–3·4) more. Life expectancies 
in 1981 and 2012 were moderately correlated (r=0·88 for 
men and 0·81 for women), but 30–40% of districts changed 
ranks by 50 or more places.
As a result of these trends, inequality in life expectancy 
across districts increased between 1981 and 2012. For 
example, the diﬀ erence between the 1st and 99th percentiles 
of district life expectancies increased from 5·2 years (95% 
credible interval 5·0–5·3) to 6·1 years (5·9–6·4) for men, 
and from 4·5 years (4·3–4·7) to 5·6 years (5·3–6·0) for 
women between 1981 and 2012. Life expectancy was lower 
in more deprived districts, and the diﬀ erence between the 
most and least deprived quintiles of districts increased 
from 2·8 years in 1981 to 3·5 years in 2012 for men, and 
from 1·9 years to 2·6 years for women (table). The 
inequality based on deprivation quintiles is smaller than 
total inequality due to within-quintile variations in life 
expectancy, which were the same size or larger than 
diﬀ erences between the least and most deprived quintiles. 
Importantly, life expectancy varied substantially more 
across districts in the two most deprived quintiles than in 
the two least deprived ones (table).
National life expectancy is expected to rise steadily and 
reach 85·7 years (95% credible interval 84·2–87·4) for 
men and 87·6 years (86·7–88·9) for women by 2030 
(ﬁ gure 1), shrinking the advantage of women compared 
with men to 1·9 years, less than a third of what it was in 
1981. About two-thirds of the forecast gains in longevity 
in men and more than three-quarters of those in women 
will be due to better survival in those older than 65 years 
of age. Life expectancy at age 65 years will rise by 
4·6 years (95% credible interval 3·1–6·3) for men and 
3·5 years (2·5–4·9) for women (ﬁ gure 4).
Life expectancy is forecast to increase in all districts, 
reaching or surpassing 81·4 years for men and reaching 
or surpassing 84·5 years for women in every district by 
2030 (ﬁ gure 1). In a few districts, life expectancy is 
expected to approach or pass 90 years for men and 92 years 
for women. The larger rise in male life expectancy than 
that of women will occur because death rates are forecast 
to fall more in men than in women, with a noticeable 
improvement in mortality of young and middle-aged adult 
men (ﬁ gure 5). By contrast, death rates in middle-aged 
and old women are estimated to decrease more slowly in 
the future than they did during the past three decades. In 
a few districts, forecast male life expectancy will be almost 
the same as that of women in 2030, whereas in 2012, the 
female advantage was at least 2·4 years in every district.
Life expectancy inequalities are expected to continue 
to rise, with the diﬀ erence between the 1st and 
99th percentiles of district life expectancies reaching 
8·3 years (95% credible interval 6·8–9·7) in men and 
8·3 years (7·1–9·4) in women in 2030. The continued 
rise in inequality will be due to increasing variation 
 Life expectancy in Q1 
(least deprived; years)
Life expectancy in Q2 
(years)
Life expectancy in Q3 
(years)
Life expectancy in Q4 
(years)
Life expectancy in Q5 
(most deprived; years)
Men
1981 73·1 (73·0–73·1; 70·9–74·4) 72·5 (72·5–72·6; 69·4–74·0) 71·9 (71·8–71·9; 69·7–73·7) 71·1 (71·1–71·1; 69·5–73·4) 70·2 (70·2–70·2; 68·5–72·6)
2012 81·5 (81·5–81·6; 80·1–82·9) 80·7 (80·7–80·8; 79·4–82·2) 79·9 (79·8–79·9; 77·8–81·6) 79·0 (78·9–79·0; 77·5–83·4) 78·0 (78·0–78·1; 75·2–82·3)
2030 87·5 (85·9–89·3; 85·9–89·4) 86·7 (85·2–88·3; 85·6–88·4) 85·9 (84·3–87·7; 83·8–88·0) 85·1 (83·5–86·8; 83·7–90·7) 84·3 (82·7–86·1; 81·4–89·8)
Women
1981 78·5 (78·4–78·5; 76·6–79·8) 78·1 (78·1–78·1; 74·1–79·8) 77·7 (77·6–77·7; 75·6–79·7) 77·3 (77·2–77·3; 75·6–80·5) 76·6 (76·5–76·6; 74·6–78·9)
2012 84·8 (84·7–84·9; 83·5–86·6) 84·2 (84·1–84·3; 82·6–86·1) 83·6 (83·6–83·7; 81·9–85·2) 82·9 (82·9–83·0; 81·2–87·3) 82·2 (82·1–82·3; 80·2–86·2)
2030 88·9 (87·9–90·2; 87·7–91·0) 88·3 (87·4–89·5; 86·7–90·6) 87·8 (86·8–88·9; 85·9–89·7) 87·1 (86·2–88·5; 85·5–92·6) 86·5 (85·5–87·7; 84·5–91·2)
Data are aggregate life expectancy, and those in parentheses are 95% credible interval; within-quintile range. Each district is assigned to a deprivation quintile on the basis of 
its 2011 Carstairs score, which combines information about unemployment, social class, crowding of housing, and (absence of) vehicle ownership. Q=quintile.
Table: Life expectancy at birth by quintile of deprivation
Figure 4: Trends and forecasts of (A) district and (B) national life expectancies at age 65 years
The solid line in A shows national life expectancy and each point shows one district. In B, national life expectancy is 
shown with its 95% credible interval. The vertical dashed line shows when forecasts begin.
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within each deprivation quintile, whereas the diﬀ erences 
between quintiles persist. Geographically, life expectancy 
will generally remain higher in the southern districts, 
with a slight weakening of the decreasing life expectancy 
gradient from south to north for men.
Discussion
Our innovative subnational mortality forecasting predicts 
that life expectancy will continue to rise in England and 
Wales both nationally and in each district. Forecast 
national life expectancies in 2030 are 85·7 years for men 
and 87·6 years for women. For comparison, the highest 
national life expectancies worldwide in 2012 were 
81·2 years for men in Iceland and 87·0 years for Japanese 
women.23 Therefore, female life expectancy in England 
and Wales in 2030 will be only slightly better than that of 
Japanese women in 2012. Most of the gains in longevity 
will be in those older than 65 years of age, and are, hence, 
highly relevant for planning pensions and health and 
social services. We also forecast that the closing of the 
female–male life expectancy gap will continue steadily. 
This narrowing will occur because death rates in 
middle-aged and old women are estimated to decrease 
more slowly in the future than they did in the past, 
perhaps partly due to accumulation of risks from 
smoking in middle-aged and older women.24
Life expectancy inequality is forecast to continue to rise 
across districts, however, with present and future 
inequalities partly related to district deprivation and 
partly associated with variation within deprivation 
quintiles, especially within the deprived quintiles. 
Furthermore, we found that life expectancy varied more 
in the more deprived quintiles, perhaps because deprived 
communities are more vulnerable to factors that aﬀ ect 
health and longevity, but vary somewhat independently 
of deprivation.
Our national forecasts of life expectancy in 2030 are 
higher than those by ONS, by 2·4 years for men and 
1·0 year for women.25 This diﬀ erence might be because 
ONS extrapolates past trends in death rates, an approach 
that, as seen in the appendix, underestimates gains in 
life expectancy.1 Our subnational forecasts cannot be 
compared with those of previous studies because 
consistent small-area forecasting of population health is 
very rare (panel). Our subnational results have both 
similarities with and diﬀ erences to the international 
scientiﬁ c literature on life expectancy and longevity. The 
highest life expectancy in the world has risen steadily 
for decades, although the country that holds the top 
position has changed.26 Life expectancies of 90 years and 
older are therefore well within ranges that most 
demographers deem feasible. Some investigators have 
noted shrinking cross-country diﬀ erences in life 
expectancy, and have advocated a worldwide so-called 
grand convergence in health,27 although others have 
noted a divergence, especially for adults.28–30 Our results 
show that national progress in the UK has come at the 
cost of rising within-country inequality, as also seen in 
the USA.31 If within-country divergences accompany 
aggregate gains elsewhere, poor health and health 
inequalities in the world will be associated more with 
Figure 5: Forecast decrease in death rates between 2012 and 2030 by age group in England and Wales’ districts
The solid line shows decrease for England and Wales, and each point shows one district.
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Panel: Research in context
Systematic review
We searched PubMed for articles published up to Feb 6, 2015, 
with no language restrictions, using the search terms 
“mortality” OR “longevity”, “forecasting”, and “spatial” OR 
“subnational” in the publication title and abstract. We also 
used a review of forecasting methods7 to identify mortality 
forecasting methods. Many attempts have been done to 
forecast mortality and life expectancy for national 
populations.3–11 Consistent forecasts for all subnational units 
within a country are, however, very rare, and tend to be for 
short periods.12 ONS projects mortality and life expectancy for 
England and Wales (but not its districts).25 Brieﬂ y, ONS 
“mortality projections are based largely on extrapolation of 
past trends in rates of mortality improvement. Expert 
opinion is used to inform the assumptions made about future 
mortality rates”.25 One of the assumptions that ONS used in 
the 2012-based projections is that the annual rates of 
decrease in death rates will converge to 1·2% for most ages in 
2037, at which it will remain thereafter.
Interpretation
We used the methods of Bayesian (spatiotemporal) statistics 
to develop new models to forecast mortality and life 
expectancy at the district level in England and Wales. We 
formulated the models to incorporate important features of 
death rates in relation to age and birth cohort, and over time 
and space. Our national life expectancy forecasts are higher 
than those of ONS. Inequalities in life expectancy across 
districts have increased over time and are forecast to rise 
steadily. Our study provides an innovative methodological 
framework for subnational mortality forecasting and 
information for subnational health and social service policies.  
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community (and individual) characteristics than with 
national boundaries and characteristics. This possibility 
should motivate steps to make within-country 
inequalities part of worldwide health accounting 
systems.
The strengths of our study are its innovative scope of 
subnational forecasts with high spatial resolution; use 
of diﬀ erent forecasting models based on characteristics 
of death rates, and their patterns over age, birth cohort, 
time, and space, for coherent and unbiased forecasts; 
and rigorous testing of model performance. The key 
limitation of our work, shared by all other attempts to 
forecast the future, is the inability to account for 
unexpected events and major changes in social and 
health systems determinants of health, which can 
fundamentally change trends and, in extreme cases, 
even lead to a reversal of life expectancy gain. We forecast 
mortality and life expectancy at the district level because 
administrative units like districts are consistent over 
time and used for resource allocation and policy 
implementation. However, people who live in each 
district might change because of migration (within the 
country and overseas).32–35 Therefore, life expectancy 
trends should not be attributed solely to changes in 
health status of individuals. Nonetheless, ﬁ ndings from 
studies in the UK34–36 and elsewhere31 have shown that 
migration is not suﬃ  cient to explain trends in health 
and health inequalities, and that these trends are largely 
due to changes in population health. Even if rising 
inequalities are partly due to migration, often by healthy 
people, from one area to another, such migration 
patterns have social and economic roots that should be 
addressed through employment opportunities, aﬀ ord-
able housing, and high-quality education and health 
care.37,38 We could not further divide the oldest (85 years 
or older) age group because geocoded population data 
were not available for age groups older than 
85 years for some years. We accounted for this data 
limitation by using a life table method designed for low-
mortality ageing populations. We measured deprivation 
at the district level, which was our unit of analysis. 
However, within-district variations exist in socio-
economic status. Finally, we did not forecast 
cause-speciﬁ c mortality, which might be relevant for 
planning of health services, and should be the subject of 
future research.
Our higher forecast life expectancy than that of ONS 
means that pensions will have larger pay-outs than 
those currently planned, and health and social services 
will have to serve an even older population, with 
chronic and comorbid disorders, than that currently 
planned. National and subnational life expectancy 
gains will, however, come at the cost of rising 
inequalities, as has been the case for the past few 
decades. An implication of rising social inequalities in 
life expectancy is that better-oﬀ  social groups, who are 
expected to live increasingly longer than will the more 
disadvantaged groups, will use health and social 
services for a longer time, creating a regressive transfer 
of resources.
Research in the UK has identiﬁ ed social policies in the 
1970s and 1980s, which diminished job security, 
increased unemployment, and worsened economic 
inequalities, as important determinants of health 
inequalities.39 Our results show that life expectancy 
inequalities have increased steadily since this period, a 
trend that is expected to continue. Furthermore, the 
present UK coalition Government has cut public 
spending on a range of social determinants of health 
under the rhetoric of austerity.40 Such policies will, at 
best, cause the rising inequality trends to continue, and 
could well worsen them because their adverse eﬀ ects are 
particularly large on children, working-age people, and 
disadvantaged social groups and communities, with 
signs of a rise in poverty already emerging.40
Access to high-quality health care can help reduce 
health inequalities through both preventive and 
lifesaving acute treatments. In the UK, use of general 
practice and many hospital services has been the same 
or even higher in people living in more deprived areas or 
from poorer socioeconomic groups, although in-
equalities might exist in use of some secondary care 
services and quality of care.41–47 Therefore universal 
health care through the National Health Service is likely 
to have had, and continue to have, an important role in 
limiting and reducing of health inequalities.48 However, 
parallel to worsening of social determinants of health, 
National Health Service reforms, which devolve health 
and social care responsibilities to local governments, 
coupled with tight budgets and an expanding role for the 
private sector in commissioning and provision of health 
services, will weaken health systems and worsen 
inequalities in health care access and quality.49–51 
Rigorous comparative analysis of health outcomes and 
their social and health system determinants at the local 
level will be essential to monitor trends and advocate 
policies and actions that maintain the rising trend in life 
expectancy but avoid a grand divergence in health and 
longevity in England and Wales.
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